These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16929071)

  • 1. Haemorrhagic vitreoretinal complications associated with combined antiplatelet agents.
    Herbert EN; Mokete B; Williamson TH; Laidlaw DA
    Br J Ophthalmol; 2006 Sep; 90(9):1209-10. PubMed ID: 16929071
    [No Abstract]   [Full Text] [Related]  

  • 2. Subretinal hemorrhages associated with age-related macular degeneration in patients receiving anticoagulation or antiplatelet therapy.
    Kuhli-Hattenbach C; Fischer IB; Schalnus R; Hattenbach LO
    Am J Ophthalmol; 2010 Feb; 149(2):316-321.e1. PubMed ID: 19939348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HEMORRHAGIC RISK OF VITREORETINAL SURGERY IN PATIENTS MAINTAINED ON NOVEL ORAL ANTICOAGULANT THERAPY.
    Grand MG; Walia HS
    Retina; 2016 Feb; 36(2):299-304. PubMed ID: 26447397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of the association between anticoagulants and intraocular hemorrhage in patients with neovascular age-related macular degeneration.
    Kiernan DF; Hariprasad SM; Rusu IM; Mehta SV; Mieler WF; Jager RD
    Retina; 2010; 30(10):1573-8. PubMed ID: 21060269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Platelet antiaggregation and hemorrhagic risk in hemodialysis].
    Sánchez Perales MC; Vázquez E; García Cortés MJ; Borrego FJ; Borrego J; Pérez del Barrio P; Liébana A; Gil JM; Viedma G; Pérez Bañasco V
    Nefrologia; 2002; 22(5):456-62. PubMed ID: 12497747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal haemorrhage after thrombolytic therapy.
    Caramelli B; Tranchesi B; Gebara OC; de Sa LC; Pileggi FJ
    Lancet; 1991 Jun; 337(8753):1356-7. PubMed ID: 1674342
    [No Abstract]   [Full Text] [Related]  

  • 7. Spontaneous macular haemorrhage in a patient on aspirin.
    Elgohary MA; Gormley PD
    J Postgrad Med; 2005; 51(2):153-5. PubMed ID: 16006717
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy.
    Brown JS; Mahmoud TH
    Retina; 2011 Nov; 31(10):1983-7. PubMed ID: 21836531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbar anesthesia and vitreoretinal surgery.
    Passemard M; Koehrer P; Juniot A; Bron AM; Creuzot-Garcher C
    Retina; 2012 Oct; 32(9):1868-73. PubMed ID: 22495328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does cardiovascular therapy affect the onset and recurrence of preretinal and vitreous haemorrhage in diabetic eye disease?
    Banerjee S; Denniston AK; Gibson JM; Dodson PM
    Eye (Lond); 2004 Aug; 18(8):821-5. PubMed ID: 14976546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute bilateral vitreo-retinal hemorrhages following oxygen-ozone therapy for lumbar disk herniation.
    Lo Giudice G; Valdi F; Gismondi M; Prosdocimo G; de Belvis V
    Am J Ophthalmol; 2004 Jul; 138(1):175-7. PubMed ID: 15234314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New modalities and aspects of antiplatelet therapy for stroke prevention.
    Uchiyama S; Nakamura T; Yamazaki M; Kimura Y; Iwata M
    Cerebrovasc Dis; 2006; 21 Suppl 1():7-16. PubMed ID: 16479097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroduodenal mucosal injury in patients on antiplatelet therapy.
    Yamamoto T; Sanaka M; Nagasawa K; Abe K; Fukami M; Nakayama S; Tsuchiya A; Ishii T; Kuyama Y
    Thromb Res; 2007; 120(4):465-9. PubMed ID: 17257659
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemorrhage associated with combined clopidogrel and aspirin therapy.
    Chapman TW; Bowley DM; Lambert AW; Walker AJ; Ashley SA; Wilkins DC
    Eur J Vasc Endovasc Surg; 2001 Nov; 22(5):478-9. PubMed ID: 11735194
    [No Abstract]   [Full Text] [Related]  

  • 15. Bleeding associated with antiplatelet agents and warfarin therapy in the emergency department.
    Kaufman MB; Alberto NA; Bailey DS
    Arch Intern Med; 2011 Jun; 171(12):1126. PubMed ID: 21709123
    [No Abstract]   [Full Text] [Related]  

  • 16. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
    Tompkins C; Cheng A; Dalal D; Brinker JA; Leng CT; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
    J Am Coll Cardiol; 2010 May; 55(21):2376-82. PubMed ID: 20488310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding risk of combined oral anticoagulant and antiplatelet therapy in cardiovascular disease.
    Verheugt FW
    J Cardiovasc Risk; 1996 Apr; 3(2):229-32. PubMed ID: 8836868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination oral antiplatelet therapy may increase the risk of hemorrhagic complications in patients with acute ischemic stroke caused by large artery disease.
    Itabashi R; Mori E; Furui E; Sato S; Yazawa Y; Fujiwara S
    Thromb Res; 2011 Dec; 128(6):541-6. PubMed ID: 21741075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse alveolar hemorrhage as a complication of dual antiplatelet therapy for acute coronary syndrome.
    Ikeda M; Tanaka H; Sadamatsu K
    Cardiovasc Revasc Med; 2011; 12(6):407-11. PubMed ID: 21514251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conundrums in the combined use of anticoagulants and antiplatelet drugs.
    Schneider DJ; Sobel BE
    Circulation; 2007 Jul; 116(3):305-15. PubMed ID: 17638939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.